Molecular Insight Pharmaceuticals, Inc.
11
Frank J. Bailey
12/09/2010
10/12/2012
Yes
v
| NTCAPR, CredAdd, TUA, CLOSED |
Assigned to: Judge Frank J. Bailey Chapter 11 Voluntary Asset Debtor disposition: Discharge Not Applicable |
|
Debtor Molecular Insight Pharmaceuticals, Inc.
160 Second Street Cambridge, MA 02142 Tax ID / EIN: 04-0562086 |
represented by |
Alan L. Braunstein
Riemer & Braunstein, LLP 100 Cambridge Street, 22nd Floor Boston, MA 02114 (617) 880-3516 Email: abraunstein@riemerlaw.com Christopher M. Candon
Sheehan Phinney Bass + Green PA 1000 Elm Street Manchester, NH 03101 (603)627-8168 Email: ccandon@sheehan.com Kenneth H. Eckstein
Kramer Levin Naftalis & Frankel, LLP 1177 Avenue of the Americas New York, NY 10036 Julia Glazer
Foley and Lardner LLP 111 Huntington Avenue Boston, MA 02199 617-342-4000 John T. Gutkoski
Hiscock & Barclay LLP 1 International Place 14th Floor Boston, MA 02110 6172742906 Fax : 6177226003 Email: jgutkoski@hblaw.com Guy B. Moss
Riemer & Braunstein, LLP 100 Cambridge Street, 22nd Floor Boston, MA 02114 (617) 523-9000 Fax : 617-880-3456 Email: gmoss@riemerlaw.com Bradley O'neill
Kramer Levin Naftalis & Frankel, LLP 1177 Avenue of Americas New York, NY 10036 Geoffrey M Raux
Foley & Lardner LLP 111 Huntington Ave. 26th Floor Boston, MA 02199 617-342-4000 Email: graux@foley.com |
Assistant U.S. Trustee John Fitzgerald
Office of the US Trustee J.W. McCormack Post Office & Courthouse 5 Post Office Sq., 10th Fl, Suite 1000 Boston, MA 02109 |
represented by |
Eric K. Bradford
Department of Justice 5 Post Office Square 10th Floor, Suite 1000 Boston, MA 02109-3934 202-306-3815 Fax : 617-565-6368 Email: Eric.K.Bradford@USDOJ.gov |
| Date Filed | # | Docket Text |
|---|---|---|
| 10/12/2012 | Bankruptcy Case Closed (nc) (Entered: 10/12/2012) | |
| 09/29/2012 | 538 | BNC Certificate of Mailing - PDF Document. RE: 537 Final Decree Notice Date 09/29/2012. (Admin.) (Entered: 09/30/2012) |
| 09/27/2012 | 537 | Final Decree dated 09/27/2012. IT IS HEREBY ORDERED, ADJUDGED AND DECREED THAT: THE MOTION IS GRANTED. THE DEBTOR SHALL PAY ALL QUARTERLY FEES COMING DUE FOLLOWING THE CLOSING OF THE CASE. THIS CHAPTER 11 CASE IS HEREBY CLOSED. SEE ORDER FOR COMPLETE TEXT. (nc) (Entered: 09/27/2012) |
| 09/11/2012 | 536 | Motion filed by Debtor Molecular Insight Pharmaceuticals, Inc. for Final Decree with certificate of service (Candon, Christopher) (Entered: 09/11/2012) |
| 09/09/2012 | 535 | BNC Certificate of Mailing - PDF Document. RE: 533 Order on Objection to Claim Notice Date 09/09/2012. (Admin.) (Entered: 09/10/2012) |
| 09/09/2012 | 534 | BNC Certificate of Mailing - PDF Document. RE: 532 Order on Objection to Claim Notice Date 09/09/2012. (Admin.) (Entered: 09/10/2012) |
| 09/07/2012 | 533 | Order dated 09/07/2012 RE: 520 Objection to Claim of Claimant (Certain Claims). IT IS HEREBY ORDERED, ADJUDGED, AND DECREED THAT: THE CLAIMS OF THE CLAIMANTS WITH RESPECT TO WHICH THE CLAIM OBJECTION IS GRANTED SHALL BE FULLY AND FINALLY DISALLOWED, OR REDUCED AND ALLOWED, IN THE AMOUNTS SET FORTH ON EXHIBITS A-F ATTACHED HERETO FOR PURPOSES OF DETERMINING THE AMOUNTS TO BE DISTRIBUTED TO THE HOLDERS OF SUCH CLAIMS, AND FOR ALL OTHER PURPOSES IN THIS CASE. . THE SEPTEMBER 11, 2012 HEARING ON THE CLAIM OBJECTION IS HEREBY CANCELED. SEE ORDER FOR COMPLETE TEXT. (nc) (Entered: 09/07/2012) |
| 09/07/2012 | 532 | Order dated 09/07/2012 RE: 519 Objection to Claim of Claimant John E. McCray. IT IS ORDERED, ADJUDGED, AND DECREED THAT: THE CLAIM OF JOHN E. MCCRAY IS HEREBY REDUCED AND FINALLY ALLOWED AS A GENERAL UNSECURED CLAIM IN THE TOTAL AMOUNT OF $130,000. THE SEPTEMBER 11, 2012 HEARING ON THE CLAIM OBJECTION IS HEREBY CANCELED. SEE ORDER FOR COMPLETE TEXT. (nc) (Entered: 09/07/2012) |
| 09/06/2012 | 531 | Supplemental to Report and Hearing Agenda [September 11, 2012 Hearing] with certificate of service (Re: 519 Objection to Claim, 529 Report & Hearing Agenda) filed by Debtor Molecular Insight Pharmaceuticals, Inc. (Candon, Christopher) (Entered: 09/06/2012) |
| 08/29/2012 | 530 | Certificate of Service (Re: 529 Report & Hearing Agenda) filed by Debtor Molecular Insight Pharmaceuticals, Inc. (Candon, Christopher) (Entered: 08/29/2012) |